Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 1) 2023
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 1) 2023
Start here
Turn the raw legal text into a practical explanation grounded in Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 1) 2023.
(1) For the purposes of section 72‑15 of the Act, this section specifies the fees that may be charged in relation to activities carried out by, or on behalf of, the Commonwealth in connection with the Minister’s consideration of: (a) a listing application relating to a medical device; or (b) a variation application relating to a medical device.
Note: Fees are not charged for listing applications, or variation applications, relating to human tissue products.
(2) The fees are: (a) a standard application fee of $1,370; and (b) if a clinical assessment is required (see section 17)—the clinical assessment fee; and (c) if an economic assessment is required (see section 18)—the economic assessment fee; and (d) if a full health technology assessment is required (see section 19)—the full health technology assessment pathway fee.